PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, China.\', \'Laboratory of Structural Biology, School of Life Sciences and School of Medicine, Tsinghua University, Beijing, China.\', \'State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China.\', \'School of Life Sciences, Tianjin University, Tianjin, China.\', \'Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.\', \'State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Response, College of Life Sciences, College of Pharmacy, Nankai University, Tianjin, China.\', \'School of Chemistry and Molecular Biosciences, the University of Queensland, Brisbane, Australia.\', \'State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China. zhangleike@wh.iov.cn.\', \'Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, ShanghaiTech University, Shanghai, China. yanght@shanghaitech.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41594-020-0440-6
?:doi
?:hasPublicationType
?:journal
  • Nature structural & molecular biology
is ?:pmid of
?:pmid
?:pmid
  • 32382072
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all